Tissue plasminogen activator treatment of stroke in type-1 diabetes rats

Neuroscience

Volumn 222, Issue , 2012, Pages 326-332

  Ning, R ^a   Chopp, M ^a,b   Yan, T ^a   Zacharek, A ^a   Zhang, C ^a   Roberts, C ^a   Cui, X ^a   Lu, M ^c   Chen, J ^a  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c Department of Biostatistics and Research Epidemiology ^*  (United States)

Author keywords

MMP 9; RAGE; Stroke; TLR4; TPA; Type 1 diabetes rats

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALTEPLASE; GELATINASE B; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ASSOCIATION; FUNCTIONAL ASSESSMENT; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROKE; WESTERN BLOTTING;

ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CEREBRAL HEMORRHAGE; COLORING AGENTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EVANS BLUE; FIBRINOLYTIC AGENTS; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 9; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; RECOVERY OF FUNCTION; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOLL-LIKE RECEPTOR 4; TREATMENT OUTCOME;

EID: 84865629675     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2012.07.018     Document Type: Article

References (57)

1. Albers G.W., Bates V.E., Clark W.M., Bell R., Verro P., Hamilton S.A. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000, 283:1145-1150.
2. Alvarez-Sabin J., Molina C.A., Montaner J., Arenillas J.F., Huertas R., Ribo M., Codina A., Quintana M. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke 2003, 34:1235-1241.
3. Barile G.R., Schmidt A.M. RAGE and its ligands in retinal disease. Curr Mol Med 2007, 7:758-765.
4. Barone F.C., Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999, 19:819-834.
5. Barth T.M., Grant M.L., Schallert T. Effects of MK-801 on recovery from sensorimotor cortex lesions. Stroke 1990, 21:III153-III157.
6. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008, 196:9-21.
7. Borlongan C.V., Randall T.S., Cahill D.W., Sanberg P.R. Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test. Brain Res 1995, 676:231-234.
8. Buchanan M.M., Hutchinson M., Watkins L.R., Yin H. Toll-like receptor 4 in CNS pathologies. J Neurochem 2010, 114:13-27.
9. Calza L., Giardino L., Giuliani A., Aloe L., Levi-Montalcini R. Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci U S A 2001, 98:4160-4165.
10. Capes S.E., Hunt D., Malmberg K., Pathak P., Gerstein H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-2432.
11. Caso J.R., Pradillo J.M., Hurtado O., Lorenzo P., Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007, 115:1599-1608.
12. Chamorro A., Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke 2006, 37:291-293.
13. Chen J., Li Y., Wang L., Lu M., Zhang X., Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 2001, 189:49-57.
14. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001, 32:2682-2688.
15. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., Lu M., Zhu Z., Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003, 92:692-699.
16. Chen J., Zhang Z.G., Li Y., Wang Y., Wang L., Jiang H., Zhang C., Lu M., Katakowski M., Feldkamp C.S., Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 2003, 53:743-751.
17. Chen J., Cui X., Zacharek A., Cui Y., Roberts C., Chopp M. White matter damage and the effect of matrix metalloproteinases in type 2 diabetic mice after stroke. Stroke 2011, 42:445-452.
18. Copin J.C., Goodyear M.C., Gidday J.M., Shah A.R., Gascon E., Dayer A., Morel D.M., Gasche Y. Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice. Eur J Neurosci 2005, 22:1597-1608.
19. Cui X., Chopp M., Zacharek A., Ye X., Roberts C., Chen J. Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol Dis 2011, 43:285-292.
20. Devaraj S., Glaser N., Griffen S., Wang-Polagruto J., Miguelino E., Jialal I. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 2006, 55:774-779.
21. Fan X., Qiu J., Yu Z., Dai H., Singhal A.B., Lo E.H., Wang X. A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes. Stroke 2012, 43:567-570.
22. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J.H., Suffredini A.F. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
23. Goeman J.J., van de Geer S.A., de Kort F., van Houwelingen H.C. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 2004, 20:93-99.
24. Hacke W., Donnan G., Fieschi C., Kaste M., von Kummer R., Broderick J.P., Brott T., Frankel M., Grotta J.C., Haley E.C., Kwiatkowski T., Levine S.R., Lewandowski C., Lu M., Lyden P., Marler J.R., Patel S., Tilley B.C., Albers G., Bluhmki E., Wilhelm M., Hamilton S. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363:768-774.
25. Hassid B.G., Nair M.N., Ducruet A.F., Otten M.L., Komotar R.J., Pinsky D.J., Schmidt A.M., Yan S.F., Connolly E.S. Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia. J Clin Neurosci 2009, 16:302-306.
26. Ihara Y., Egashira K., Nakano K., Ohtani K., Kubo M., Koga J., Iwai M., Horiuchi M., Gang Z., Yamagishi S., Sunagawa K. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis. J Mol Cell Cardiol 2007, 43:455-464.
27. Ishibashi T., Kawaguchi M., Sugimoto K., Uekita H., Sakamoto N., Yokoyama K., Maruyama Y., Takeishi Y. Advanced glycation end product-mediated matrix metallo-proteinase-9 and apoptosis via renin-angiotensin system in type 2 diabetes. J Atheroscler Thromb 2010, 17:578-589.
28. Ishii I., Ye X., Friedman B., Kawamura S., Contos J.J., Kingsbury M.A., Yang A.H., Zhang G., Brown J.H., Chun J. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J Biol Chem 2002, 277:25152-25159.
29. Jialal I., Devaraj S., Venugopal S.K. Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy. Free Radic Res 2002, 36:1331-1336.
30. Kumari R., Willing L.B., Patel S.D., Baskerville K.A., Simpson I.A. Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke. J Neurochem 2011, 119:1029-1040.
31. Li Y., Jiang N., Powers C., Chopp M. Neuronal damage and plasticity identified by microtubule-associated protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats. Stroke 1998, 29:1972-1980. discussion 1980-1971.
32. Lu M., Chen J., Lu D., Yi L., Mahmood A., Chopp M. Global test statistics for treatment effect of stroke and traumatic brain injury in rats with administration of bone marrow stromal cells. J Neurosci Methods 2003, 128:183-190.
33. Maillard-Lefebvre H., Boulanger E., Daroux M., Gaxatte C., Hudson B.I., Lambert M. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases. Rheumatology 2009, 48:1190-1196.
34. Markgraf C.G., Green E.J., Hurwitz B.E., Morikawa E., Dietrich W.D., McCabe P.M., Ginsberg M.D., Schneiderman N. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res 1992, 575:238-246.
35. Mast H., Thompson J.L., Lee S.H., Mohr J.P., Sacco R.L. Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. Stroke 1995, 26:30-33.
36. Muhammad S., Barakat W., Stoyanov S., Murikinati S., Yang H., Tracey K.J., Bendszus M., Rossetti G., Nawroth P.P., Bierhaus A., Schwaninger M. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008, 28:12023-12031.
37. Murase S., McKay R.D. Matrix metalloproteinase-9 regulates survival of neurons in newborn hippocampus. J Biol Chem 2012, 287:12184-12194.
38. Niessen F., Hilger T., Hoehn M., Hossmann K.A. Thrombolytic treatment of clot embolism in rat: comparison of intra-arterial and intravenous application of recombinant tissue plasminogen activator. Stroke 2002, 33:2999-3005.
39. Origlia N., Capsoni S., Cattaneo A., Fang F., Arancio O., Yan S.D., Domenici L. Abeta-dependent inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE. J Alzheimers Dis 2009, 17:59-68.
40. Putaala J., Liebkind R., Gordin D., Thorn L.M., Haapaniemi E., Forsblom C., Groop P.H., Kaste M., Tatlisumak T. Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis. Neurology 2011, 76:1831-1837.
41. Qiu J., Xu J., Zheng Y., Wei Y., Zhu X., Lo E.H., Moskowitz M.A., Sims J.R. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke 2010, 41:2077-2082.
42. Schallert T., Upchurch M., Lobaugh N., Farrar S.B., Spirduso W.W., Gilliam P., Vaughn D., Wilcox R.E. Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol Biochem Behav 1982, 16:455-462.
43. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39:777-787.
44. Schmidt A.M., Hori O., Chen J.X., Li J.F., Crandall J., Zhang J., Cao R., Yan S.D., Brett J., Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995, 96:1395-1403.
45. Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001, 108:949-955.
46. Schwenger V., Zeier M., Henle T., Ritz E. Advanced glycation endproducts (AGEs) as uremic toxins. Die Nahrung 2001, 45:172-176.
47. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990, 10:290-293.
48. Tu X.K., Yang W.Z., Liang R.S., Shi S.S., Chen J.P., Chen C.M., Wang C.H., Xie H.S., Chen Y., Ouyang L.Q. Effect of baicalin on matrix metalloproteinase-9 expression and blood-brain barrier permeability following focal cerebral ischemia in rats. Neurochem Res 2011, 36:2022-2028.
49. Vlassara H., Palace M.R. Diabetes and advanced glycation endproducts. J Intern Med 2002, 251:87-101.
50. Williams M.D., Nadler J.L. Inflammatory mechanisms of diabetic complications. Curr Diab Rep 2007, 7:242-248.
51. Won S.J., Tang X.N., Suh S.W., Yenari M.A., Swanson R.A. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by increasing superoxide production. Ann Neurol 2011, 70:583-590.
52. Wu K.K., Huan Y. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol Chapter 5. Unit5 2008, 47.
53. Yamamoto Y., Kato I., Doi T., Yonekura H., Ohashi S., Takeuchi M., Watanabe T., Yamagishi S., Sakurai S., Takasawa S., Okamoto H., Yamamoto H. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 2001, 108:261-268.
54. Yan S.F., Ramasamy R., Naka Y., Schmidt A.M. Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 2003, 93:1159-1169.
55. Ye X., Chopp M., Liu X., Zacharek A., Cui X., Yan T., Roberts C., Chen J. Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats. Neuroscience 2011, 190:339-345.
56. Zhang R.L., Chopp M., Zhang Z.G., Jiang Q., Ewing J.R. A rat model of focal embolic cerebral ischemia. Brain Res 1997, 766:83-92.
57. Zhang Z.G., Zhang L., Croll S.D., Chopp M. Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience 2002, 113:683-687.